{
  "pmcid": "11860008",
  "sha256": "529636847aa61a61beea4585721143d2b40c765e5281e520f0495f97e96c1509",
  "timestamp_utc": "2025-11-09T23:21:42.423450+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 15.275257034632038,
    "reading_ease": 11.261456980519483,
    "word_count": 231
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of a Dynamic Age-Dependent PBPK Model for Drug Pharmacokinetics"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Participants": {
        "score": 1,
        "evidence": "The study setting was virtual, involving 1000 simulated individuals."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Four CYP3A substrates—midazolam, fentanyl, alfentanil, and sufentanil—served as model drugs."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aimed to develop a dynamic age-dependent physiologically based pharmacokinetic (PBPK) model to predict drug pharmacokinetics across different ages."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the prediction accuracy of plasma concentrations, measured over a simulated timeframe."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Randomisation and allocation concealment methods were not applicable."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Blinding was not used as this was a simulation study."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "The study setting was virtual, involving 1000 simulated individuals."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "Observed plasma concentrations mostly fell within the 5th–95th percentile of predicted values in 1000 virtual individuals."
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: Not applicable."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 10,
    "max_score": 25
  }
}